Response of transcription factor NFATc3 to excitotoxic and traumatic brain insults: Identification of a subpopulation of reactive astrocytes

GLIA

Volumn 59, Issue 1, 2011, Pages 94-107

  Serrano Pérez, María C ^a   Martín, Eduardo D ^a   Vaquero, Cecilia F ^b   Azcoitia, Iñigo ^c   Calvo, Soledad ^a   Cano, Eva ^d   Tranque, Pedro ^a  

^a Universidad Castilla La Mancha   (Spain)

^b University of Castilla La Mancha   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Astrogliosis; Brain lesion; Glia; Glial scar; Neuroinflammation

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; MESSENGER RNA; TRANSCRIPTION FACTOR NFAT3; TRANSCRIPTION FACTOR NFATC3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SUBPOPULATION; EXCITOTOXICITY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; BRAIN INJURIES; CELL DEATH; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MICE; MICROSCOPY, CONFOCAL; NEURONS; NFATC TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78349297520     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21079     Document Type: Article

References (63)

1. Abbracchio MP, Ceruti S. 2006. Roles of P2 receptors in glial cells: Focus on astrocytes. Purinergic Signal 2: 595-604.
2. Abdul HM, Furman JL, Sama MA, Mathis DM, Norris CM. 2010. NFATs and Alzheimer's disease. Mol Cell Pharmacol 2: 7-14.
3. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, Patel ES, Baig I, Murphy MP, LeVine H, III, Kraner SD, Norris CM. 2009. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29: 12957-12969.
4. Aramburu J, Heitman J, Crabtree GR. 2004. Calcineurin: A central controller of signaling in eukaryotes. EMBO Rep 5: 343-348.
5. Blanco A, Alvarez S, Fresno M, Munoz-Fernandez MA. 2008. Extracellular HIV-Tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells. J Immunol 180: 530-540.
6. Blom MA, van Twillert MG, de Vries SC, Engels F, Finch CE, Veerhuis R, Eikelenboom P. 1997. NSAIDS inhibit the IL-1beta-induced IL-6 release from human post-mortem astrocytes: The involvement of prostaglandin E2. Brain Res 777: 210-218.
7. Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, Mori T, Gotz M. 2008. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain. Proc Natl Acad Sci USA 105: 3581-3586.
8. Buffo A, Rolando C, Ceruti S. 2010. Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79: 77-89.
9. Canellada A, Ramirez BG, Minami T, Redondo JM, Cano E. 2008. Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes. Glia 56: 709-722.
10. Cano E, Canellada A, Minami T, Iglesias T, Redondo JM. 2005. Depolarization of neural cells induces transcription of the down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. J Biol Chem 280: 29435-29443.
11. Che Y, Yu YM, Han PL, Lee JK. 2001. Delayed induction of p38 MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure. Brain Res Mol Brain Res 94: 157-165.
12. Chen Z, Ljunggren HG, Bogdanovic N, Nennesmo I, Winblad B, Zhu J. 2002. Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice. Brain Res 931: 135-145.
13. Cho IH, Im JY, Kim D, Kim KS, Lee JK, Han PL. 2003. Protective effects of extracellular glutathione against Zn2+-induced cell death in vitro and in vivo. J Neurosci Res 74: 736-743.
14. Chow CW, Davis RJ. 2000. Integration of calcium and cyclic AMP signaling pathways by 14-3-3. Mol Cell Biol 20: 702-712.
15. Chow CW, Rincon M, Cavanagh J, Dickens M, Davis RJ. 1997. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278: 1638-1641.
16. Crabtree GR, Olson EN. 2002. NFAT signaling: Choreographing the social lives of cells. Cell 109 (Suppl): S67-S79.
17. Davies KJ, Ermak G, Rothermel BA, Pritchard M, Heitman J, Ahnn J, Henrique-Silva F, Crawford D, Canaider S, Strippoli P, Carinci P, Min KT, Fox DS, Cunningham KW, Bassel-Duby R, Olson EN, Zhang Z, Williams RS, Gerber HP, Perez-Riba M, Seo H, Cao X, Klee CB, Redondo JM, Maltais LJ, Bruford EA, Povey S, Molkentin JD, McKeon FD, Duh EJ, Crabtree GR, Cyert MS, de la LS, Estivill X. 2007. Renaming the DSCR1/Adapt78 gene family as RCAN: Regulators of calcineurin. FASEB J 21: 3023-3028.
18. Dawson TM, Steiner JP, Lyons WE, Fotuhi M, Blue M, Snyder SH. 1994. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: Relationship to calcineurin. Neuroscience 62: 569-580.
19. Diehl S, Chow CW, Weiss L, Palmetshofer A, Twardzik T, Rounds L, Serfling E, Davis RJ, Anguita J, Rincon M. 2002. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J Exp Med 196: 39-49.
20. Dienz O, Eaton SM, Krahl TJ, Diehl S, Charland C, Dodge J, Swain SL, Budd RC, Haynes L, Rincon M. 2007. Accumulation of NFAT mediates IL-2 expression in memory, but not naive, CD4+ T cells. Proc Natl Acad Sci USA 104: 7175-7180.
21. Fernandez AM, Fernandez S, Carrero P, Garcia-Garcia M, Torres-Aleman I. 2007. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J Neurosci 27: 8745-8756.
22. Filosa JA, Nelson MT, Gonzalez Bosc LV. 2007. Activity-dependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels. Am J Physiol Cell Physiol 293: C1797-C1805.
23. Franklin G, Paxinos K. 2001. The mouse brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press. p 264.
24. Friedman LK. 2006. Calcium: A role for neuroprotection and sustained adaptation. Mol Interv 6: 315-329.
25. Graef IA, Chen F, Crabtree GR. 2001. NFAT signaling in vertebrate development. Curr Opin Genet Dev 11: 505-512.
26. Graef IA, Crabtree GR, Wang F. 2006. Calcineurin/NFAT signaling in development and function of the nervous system. In: Gerald Thiel, editor. Transcription factors in the nervous system: Development, brain function, and diseases. Weinheim: Wiley-VCH. pp 353-378.
27. Hogan PG, Chen L, Nardone J, Rao A. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205-2232.
28. Hua LL, Zhao ML, Cosenza M, Kim MO, Huang H, Tanowitz HB, Brosnan CF, Lee SC. 2002. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J Neuroimmunol 126: 180-189.
29. Jones EA, Sun D, Kobierski L, Symes AJ. 2003. NFAT4 is expressed in primary astrocytes and activated by glutamate. J Neurosci Res 72: 191-197.
30. Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA, Crabtree GR. 2009. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323: 651-654.
31. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, Olson EN. 2006. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 116: 3114-3126.
32. Kyrkanides S, Moore AH, Olschowka JA, Daeschner JC, Williams JP, Hansen JT, O'Banion MK. 2002. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res 104: 159-169.
33. Laird MD, Vender JR, Dhandapani KM. 2008. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16: 154-164.
34. Lerma J, Paternain AV, Rodriguez-Moreno A, Lopez-Garcia JC. 2001. Molecular physiology of kainate receptors. Physiol Rev 81: 971-998.
35. Liu Q, Busby JC, Molkentin JD. 2009. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signaling nodal control point. Nat Cell Biol 11: 154-161.
36. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR, the 2(-ΔΔC(T)) method. Methods 25: 402-408.
37. Lobsiger CS, Cleveland DW. 2007. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10: 1355-1360.
38. Loscher W. 2002. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50: 105-123.
39. Lyakh L, Ghosh P, Rice NR. 1997. Expression of NFAT-family proteins in normal human T cells. Mol Cell Biol 17: 2475-2484.
40. Macian F. 2005. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 5: 472-484.
41. Macian F, Lopez-Rodriguez C, Rao A. 2001. Partners in transcription: NFAT and AP-1. Oncogene 20: 2476-2489.
42. Matyash V, Kettenmann H. 2009. Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 63:2-10.
43. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T, Kodama T, Aird WC. 2004. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279: 50537-50554.
44. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. 2006. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129: 2761-2772.
45. Nilsson LM, Sun ZW, Nilsson J, Nordstrom I, Chen YW, Molkentin JD, Wide-Swensson D, Hellstrand P, Lydrup ML, Gomez MF. 2007. Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 292: C1167-C1178.
46. Norris CM, Kadish I, Blalock EM, Chen KC, Thibault V, Porter NM, Landfield PW, Kraner SD. 2005. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J Neurosci 25: 4649-4658.
47. Okamura H, Garcia-Rodriguez C, Martinson H, Qin J, Virshup DM, Rao A. 2004. A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol Cell Biol 24: 4184-4195.
48. Park HJ, Kim HJ, Park HJ, Ra J, Zheng LT, Yim SV, Chung JH. 2008. Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus. Epilepsia 49: 163-167.
49. Perez-Ortiz JM, Serrano-Perez MC, Pastor MD, Martin ED, Calvo S, Rincon M, Tranque P. 2008. Mechanical lesion activates newly identified NFATc1 in primary astrocytes: Implication of ATP, purinergic receptors. Eur J Neurosci 27: 2453-2465.
50. Perez-Ortiz JM, Tranque P, Vaquero CF, Domingo B, Molina F, Calvo S, Jordan J, Cena V, Llopis J. 2004. Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma. J Biol Chem 279: 8976-8985.
51. Renault-Mihara F, Okada S, Shibata S, Nakamura M, Toyama Y, Okano H. 2008. Spinal cord injury: Emerging beneficial role of reactive astrocytes' migration. Int J Biochem Cell Biol 40: 1649-1653.
52. Rolls A, Shechter R, Schwartz M. 2009. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10: 235-241.
53. Sama MA, Mathis DM, Furman JL, Abdul HM, Artiushin IA, Kraner SD, Norris CM. 2008. Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem 283: 21953-21964.
54. Schmued LC, Stowers CC, Scallet AC, Xu L. 2005. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035: 24-31.
55. Schwarcz R. 2008. Early glial dysfunction in epilepsy. Epilepsia 49 Suppl 2: 1-2.
56. Serfling E, Chuvpilo S, Liu J, Hofer T, Palmetshofer A. 2006. NFATc1 autoregulation: A crucial step for cell-fate determination. Trends Immunol 27: 461-469.
57. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119: 7-35.
58. Somera-Molina KC, Robin B, Somera CA, Anderson C, Stine C, Koh S, Behanna HA, Van Eldik LJ, Watterson DM, Wainwright MS. 2007. Glial activation links early-life seizures and long-term neurologic dysfunction: Evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 48: 1785-1800.
59. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901.
60. Takuma K, Baba A, Matsuda T. 2004. Astrocyte apoptosis: Implications for neuroprotection. Prog Neurobiol 72: 111-127.
61. Weigmann B, Lehr HA, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Schmidt J, Galle PR, Rose-John S, Neurath MF. 2008. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med 205: 2099-2110.
62. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS. 2000. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87: E61-E68.
63. Zhou B, Cron RQ, Wu B, Genin A, Wang Z, Liu S, Robson P, Baldwin HS. 2002. Regulation of the murine Nfatc1 gene by NFATc2. J Biol Chem 277: 10704-10711.